Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy

Cesare Hassan, V De Francesco, A Zullo, G Scaccianoce, D Piglionica, E Ierardi, C Panella, S. Morini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

42 Citazioni (Scopus)

Abstract

Several studies have shown that Helicobacter pylori eradication rates with standard 7-day triple therapy are unsatisfactory. A novel 10-day sequential treatment regimen recently achieved a significantly higher eradication rate. To improve the pharmacotherapeutic cost, we evaluated whether an acceptable eradication rate could be achieved in peptic ulcer patients by halving the dose of clarithromycin.
Lingua originaleEnglish
pagine (da-a)641-646
Numero di pagine6
RivistaALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume18
Stato di pubblicazionePubblicato - 2003
Pubblicato esternamenteYes

Keywords

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Adult
  • Aged
  • Amoxicillin
  • Antacids
  • Anti-Ulcer Agents
  • Benzimidazoles
  • Clarithromycin
  • Cost-Benefit Analysis
  • Drug Costs
  • Drug Therapy, Combination
  • Duodenal Ulcer
  • Female
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Male
  • Middle Aged
  • Omeprazole
  • Prospective Studies
  • Tinidazole
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy'. Insieme formano una fingerprint unica.

Cita questo